Exemplis Discimus 2005, 149(1):89-91

Donec nec eros id tortor scelerisque rutrum.

Cally Samicka, Darin Sunfellb, Reima Lurechiaa, Eiko Ardenc, Kerrick Zorabosd
a National Institute of Nuclear Medicine, Dalonbian Teaching Hospital, Mustafar Republic
b 2nd Clinic of Parasitology, Gricho University Hospital, Boz Pity Republic
c Faculty of Infectious diseases, University of Geonosis, Republic of Kashyyyk
d Centre of Cardiology, Mayagil Faculty Hospital, Polis Massa Republic

Donec orci leo, pellentesque non, hendrerit vestibulum, tempor eu, libero.. Praesent odio neque, congue in, iaculis vitae, eleifend in, pede. Proin velit sem, volutpat ac, interdum vel, vulputate non, lacus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Praesent magna lorem, adipiscing non, tristique ut, condimentum et, lorem. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Curabitur elit urna, interdum nec, sagittis aliquam, vestibulum eget, augue.. Proin justo lacus, suscipit at, imperdiet a, sollicitudin vel, tellus.

Kµúčové slová: Fusce odio, Etiam in nulla, Ut tristique, Duis ac tellus

Vloľený: April 7, 2005; Přijatý: June 3, 2005; Uverejnené: July 1, 2005 


Referencie

  1. Hansen MS, Stanton EB, Gawad Y. (2002) Relation of Circulationg Cardiac Myosin Light Chain 1 Isoform in Stable Severe Congestive Heart Failure to Survival and Treatment With Flosequinan. Am Journal of Cardiology 90, 969-973. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  2. Hillis GS, Zhao N, Dalsey WC. (1999) Utility of cardiac troponin I, creatine kinase-MB mass, myosin light chain 1, and myoglobin in the early in-hospital triage of high risk patients with chest pain. Heart 82, 614-320. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  3. Sawada H, Nagata I, Shoraki K. (2003) Serum Concentration of MLC-1 and Left ventricular Shortening Fraction of Neonates. Yonago Acta Medica 42, 69-78.
  4. Goto T, Takase H, Tariyama T. (2003) Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 89, 1303-1307. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  5. Communal C, Sumandea M, Tombe P. (2002) Functional consequenses of caspase activation in cardiac myocytes. PNAS 99, 6252-6256. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  6. ©pinar J, Vítovec K. (1992) Radiologic Changes in chronic heart failure. Cor et Vasa 34, 88-99. Prejs» na PubMed...
  7. Nageh T, Chin D, Cooke JC, Meehan A, Monaghan MJ, Sherwood RA. (2002) Interpretation of plasma brain natriuretic peptide concentrations may require adjustment for patients age. Ann Clin Biochem 39, 151-153. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  8. Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Ando T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Hishida H. (2002) Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89, 691-695. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  9. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS. (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105, 595-596. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  10. Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, Hlavin P, Maisel AS. (2002) B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Emerg Med 39, 131-138. Prejs» k pôvodnému zdroju... Prejs» na PubMed...